Closed-Loop Insulin System Improves Glucose Control in Pregnant Women with Type 1 Diabetes
A recent study published in JAMA, known as the CIRCUIT trial, has shown that pregnant women with type 1 diabetes who used a closed-loop insulin delivery system had better glucose control compared to those receiving standard care.
The study found that women using the closed-loop system spent more time within the pregnancy-specific glucose range, with less time above or below targets, and had lower average glucose and HbA1c levels.
The randomized CIRCUIT trial has found that pregnant women with type 1 diabetes who used a closed-loop insulin delivery system spent significantly more time within the pregnancy-specific glucose range.
This research was summarized by Dr. Kamal Kant Kohli, a chest specialist and Chief Editor of Medical News at Medical Dialogues.
Author's summary: Closed-loop insulin system improves glucose control in pregnant women with type 1 diabetes.
More News
- The price of going cashless
- In response to ‘The DMV: Humanity’s greatest crime against itself’
- BlockDAG’s $0.0015 TGE Code Offers VIP Early Access, Outshining Ozak AI and Avalon X Presales
- Thousands of international students' scholarship contracts to be tightened after ELTE scandal
- Binance & AAVE Show Signs of Slowdown While BlockDAG Climbs to $432M+ & Prepares For Genesis Day
- Council facing £40m budget gap next year as officers warn savings need to be found
- Tackling youth vaping: Current regulations fall short and new tech offers effective solutions
- The Sundarbans: Our shield against climate change
- AI cyber attacks: The Halloween edition